I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 3 studies | 22% ± 3% | |
| GABAergic neuron | 3 studies | 30% ± 3% | |
| glutamatergic neuron | 3 studies | 33% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 3 studies | 22% ± 3% | |
| GABAergic neuron | 3 studies | 30% ± 3% | |
| glutamatergic neuron | 3 studies | 33% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1256.92 | 653 / 653 | 100% | 9.97 | 604 / 605 |
| brain | 100% | 771.28 | 2637 / 2642 | 100% | 10.66 | 704 / 705 |
| prostate | 100% | 743.94 | 245 / 245 | 99% | 7.39 | 499 / 502 |
| breast | 100% | 750.26 | 459 / 459 | 99% | 7.02 | 1109 / 1118 |
| lung | 100% | 749.28 | 577 / 578 | 99% | 5.60 | 1147 / 1155 |
| kidney | 100% | 812.36 | 89 / 89 | 99% | 9.14 | 893 / 901 |
| esophagus | 100% | 697.31 | 1445 / 1445 | 99% | 5.45 | 181 / 183 |
| adrenal gland | 100% | 1082.91 | 258 / 258 | 98% | 10.38 | 226 / 230 |
| intestine | 100% | 749.76 | 966 / 966 | 98% | 6.72 | 517 / 527 |
| liver | 100% | 582.58 | 226 / 226 | 98% | 5.80 | 398 / 406 |
| stomach | 100% | 624.77 | 359 / 359 | 98% | 6.50 | 280 / 286 |
| uterus | 100% | 790.61 | 170 / 170 | 98% | 6.61 | 448 / 459 |
| ovary | 100% | 963.22 | 180 / 180 | 97% | 4.20 | 418 / 430 |
| bladder | 100% | 676.90 | 21 / 21 | 97% | 5.82 | 488 / 504 |
| pancreas | 97% | 259.99 | 318 / 328 | 99% | 6.23 | 176 / 178 |
| skin | 100% | 476.74 | 1803 / 1809 | 95% | 7.43 | 447 / 472 |
| adipose | 100% | 785.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 732.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.92 | 29 / 29 |
| spleen | 100% | 788.23 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.25 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.05 | 1 / 1 |
| muscle | 100% | 401.72 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 499.32 | 844 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 674.03 | 910 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 4.69 | 71 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070383 | Biological process | DNA cytosine deamination |
| GO_0009972 | Biological process | cytidine deamination |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0004132 | Molecular function | dCMP deaminase activity |
| GO_0061676 | Molecular function | importin-alpha family protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0004126 | Molecular function | cytidine deaminase activity |
| Gene name | CDADC1 |
| Protein name | Cytidine and dCMP deaminase domain-containing protein 1 (EC 3.5.4.5) (Cytidine deaminase) (Testis development protein NYD-SP15) Cytidine and dCMP deaminase domain containing 1 CDADC1 protein |
| Synonyms | |
| Description | FUNCTION: Catalyzes the deamination of cytidine and deoxycytidine into uridine and deoxyuridine, respectively . May play an important role in testicular development and spermatogenesis . . |
| Accessions | H0Y447 ENST00000496061.5 Q569J7 F2Z2J8 Q6NSE0 F2Z2H0 ENST00000484126.5 ENST00000429346.1 Q9BWV3 ENST00000251108.10 [Q9BWV3-1] |
